NEJM This Week — October 8, 2020
Featuring articles on empagliflozin in heart failure, cardiovascular outcomes with ertugliflozin in diabetes, dapagliflozin in chronic kidney disease, single or dual antiplatelet treatment after TAVI, on dying in a leadership vacuum, Covid-19 and implications for the health care system, and mending mitochondrial mutation; a review article on secondary mitral regurgitation; a case report of a man with lymphoma and abdominal pain; and Perspective articles on the role of market forces in U.S. health care, on embracing antiracism in medicine, and on improving clinical trial enrollment.
